MiMedx Group, Inc. (MDXG)
4.67
+0.05
(+1.08%)
USD |
NASDAQ |
Oct 09, 16:00
4.675
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Max Drawdown (5Y) : 85.36% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 85.36% |
| August 31, 2026 | 85.36% |
| July 31, 2026 | 85.36% |
| June 30, 2026 | 85.36% |
| May 31, 2026 | 85.36% |
| April 30, 2026 | 85.36% |
| March 31, 2026 | 85.36% |
| February 28, 2026 | 85.36% |
| January 31, 2026 | 85.36% |
| December 31, 2025 | 85.36% |
| November 30, 2025 | 85.36% |
| October 31, 2025 | 85.36% |
| September 30, 2025 | 85.36% |
| August 31, 2025 | 85.36% |
| July 31, 2025 | 85.36% |
| June 30, 2025 | 85.36% |
| May 31, 2025 | 85.36% |
| April 30, 2025 | 85.36% |
| March 31, 2025 | 85.36% |
| February 28, 2025 | 85.36% |
| January 31, 2025 | 85.36% |
| December 31, 2024 | 85.36% |
| November 30, 2024 | 85.36% |
| October 31, 2024 | 85.36% |
| September 30, 2024 | 85.36% |
| Date | Value |
|---|---|
| August 31, 2024 | 85.36% |
| July 31, 2024 | 85.36% |
| June 30, 2024 | 85.36% |
| May 31, 2024 | 85.36% |
| April 30, 2024 | 85.80% |
| March 31, 2024 | 86.80% |
| February 29, 2024 | 86.80% |
| January 31, 2024 | 86.80% |
| December 31, 2023 | 90.03% |
| November 30, 2023 | 93.60% |
| October 31, 2023 | 93.60% |
| September 30, 2023 | 93.60% |
| August 31, 2023 | 93.60% |
| July 31, 2023 | 93.60% |
| June 30, 2023 | 93.60% |
| May 31, 2023 | 93.60% |
| April 30, 2023 | 93.60% |
| March 31, 2023 | 93.60% |
| February 28, 2023 | 93.60% |
| January 31, 2023 | 93.60% |
| December 31, 2022 | 93.60% |
| November 30, 2022 | 93.60% |
| October 31, 2022 | 93.60% |
| September 30, 2022 | 93.60% |
| August 31, 2022 | 93.60% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Anika Therapeutics, Inc. | 83.15% |
| Perspective Therapeutics, Inc. | 93.08% |
| ABVC BioPharma, Inc. | 99.79% |
| Enovis Corp. | 80.40% |
| Edwards Lifesciences Corp. | 54.32% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.69 |
| Beta (5Y) | 1.178 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.23% |
| Historical Sharpe Ratio (5Y) | -0.1408 |
| Historical Sortino (5Y) | -0.283 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.83% |